(RTTNews) - Abbott (ABT) has received FDA clearance for its Alinity m STI Assay test, which simultaneously detects and differentiates four common sexually transmitted infections. The Alinity m STI ...
Credit: Getty Images. The Alinity m STI Assay uses in vitro RT-PCR technology with high sensitivity to detect and differentiate STIs from symptomatic and asymptomatic individuals. The Food and Drug ...
According to the U.S. Centers for Disease Control (CDC), most sexually active adults will experience HPV infections; new test detects those HPV genotypes that could lead to cancer Abbott (ABT)'s new ...
Abbott's multiplex test runs on its most advanced molecular PCR platform, the Alinity™ m system, which provides fast results in high volumes – detecting four infections simultaneously Test provides a ...
ABBOTT PARK, Ill., Nov. 2, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) has received U.S. Food and Drug Administration (FDA) approval for its molecular human papillomavirus or HPV screening solution, ...